# Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.

> **NCT03619330** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 30 (actual)

## Conditions studied

- Hypogonadism
- Obesity

## Interventions

- **DRUG:** liraglutide
- **DRUG:** Testosterone

## Key facts

- **NCT ID:** NCT03619330
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03619330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03619330, "Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03619330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*